(Q36001510)

11 August 2017

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer (English)

1 reference

11 August 2017

1 reference

6

C Caldas

1 reference

11 August 2017

5

P D Pharoah

1 reference

11 August 2017

H R Ali

1

1 reference

11 August 2017

S-J Dawson

series ordinal

2

1 reference

11 August 2017

F M Blows

series ordinal

3

1 reference

11 August 2017

E Provenzano

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

26 April 2012

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

106

1 reference

11 August 2017

1798-1806

1 reference

11 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2012.167

11 August 2017

0 references

cites work

A three-gene model to robustly identify breast cancer molecular subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Shared and separate functions of polo-like kinases and aurora kinases in cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Ki67 in breast cancer: prognostic and predictive potential

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Cell cycle markers in clinical oncology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

A consensus prognostic gene expression classifier for ER positive breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

DNA replication licensing and cell cycle kinetics of normal and neoplastic breast

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Effect of screening and adjuvant therapy on mortality from breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Proliferation marker Ki-67 in early breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Aurora-kinase inhibitors as anticancer agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Molecular classification of breast carcinomas using tissue microarrays

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Cyclin E and survival in patients with breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Potential for selection bias with tumor tissue retrieval in molecular epidemiology studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Molecular portraits of human breast tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Tissue microarrays for high-throughput molecular profiling of tumor specimens

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer.

2 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Automated subcellular localization and quantification of protein expression in tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Control of DNA replication and its potential clinical exploitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Adjuvant chemotherapy is not for everyone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Using the outcome for imputation of missing predictor values was preferred.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Genetics: How to validate a breast cancer prognostic signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365239

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

23 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.167

Value of Ki67 in breast cancer: the debate is still open

21 January 2018

1 reference

12 December 2020

The cell cycle and cancer

1 reference

12 December 2020

Tissue microarrays for comparing molecular features with proliferation activity in breast cancer

1 reference

12 December 2020

Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen

1 reference

12 December 2020

Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.167

1 reference

release_3dhbvlvminh5jg3vzd2oeg73we

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3dhbvlvminh5jg3vzd2oeg73we

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

1 reference